Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypes
- PMID: 12824435
- PMCID: PMC168981
- DOI: 10.1093/nar/gkg575
Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypes
Abstract
Therapeutic success of anti-HIV therapies is limited by the development of drug resistant viruses. These genetic variants display complex mutational patterns in their pol gene, which codes for protease and reverse transcriptase, the molecular targets of current antiretroviral therapy. Genotypic resistance testing depends on the ability to interpret such sequence data, whereas phenotypic resistance testing directly measures relative in vitro susceptibility to a drug. From a set of 650 matched genotype-phenotype pairs we construct regression models for the prediction of phenotypic drug resistance from genotypes. Since the range of resistance factors varies considerably between different drugs, two scoring functions are derived from different sets of predicted phenotypes. Firstly, we compare predicted values to those of samples derived from 178 treatment-naive patients and report the relative deviance. Secondly, estimation of the probability density of 2000 predicted phenotypes gives rise to an intrinsic definition of a susceptible and a resistant subpopulation. Thus, for a predicted phenotype, we calculate the probability of membership in the resistant subpopulation. Both scores provide standardized measures of resistance that can be calculated from the genotype and are comparable between drugs. The geno2pheno system makes these genotype interpretations available via the Internet (http://www.genafor.org/).
Figures



References
-
- Perrin L. and Telenti,A. (1998) HIV treatment failure: testing for HIV resistance in clinical practice. Science, 280, 1871–1873. - PubMed
-
- Vandamme A.M., Van Laethem,K. and De Clerq,E. (1999) Managing resistance to anti-HIV drugs: an important consideration for effective disease management. Drugs, 57, 337–361. - PubMed
-
- Walter H., Schmidt,B., Korn,K., Vandamme,A.M., Harrer,T. and Überla,K. (1999) Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors. J. Clin. Virol., 13, 71–80. - PubMed
-
- DeGruttola V., Dix,L., D'Aquila,R., Holder,D., Phillips,A., Ait-Khaled,M., Baxter,J., Clevenbergh,P., Hammer,S., Harrigan,R. et al. (2000) The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan. Antivir. Ther., 5, 41–48. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources